----

----

| 1. | Definitions | Unless      expressly stated to the contrary, the following definitions shall govern      the interpretation and enforcement of this  Agreement: |
|----|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term "Subsidiary" shall mean and refer to any corporation or other entity      (i) the majority of whose shares or other securities entitled to vote for      election of directors (or other managing authority) is now or hereafter      controlled by a Party, either directly or indirectly, or (ii) which does      not have outstanding shares or securities but the majority of whose      ownership interest representing the right to manage such corporation or      other legal entity is now or hereafter owned or controlled by a Party,      either directly or indirectly.  Any such corporation or other      legal entity shall be deemed to be a Subsidiary of a Party only so long as      such control or ownership exists. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “Effective Date” shall mean and refer to the later to occur of (i)      the date of the last signature on this Agreement, (ii) the entry of a      fully executed Stipulation of Dismissal in the form attached hereto as      Exhibit A, and (iii) the entry of a fully executed Stipulation of      Dismissal in the form attached hereto as Exhibit  B. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “STOP” shall mean and refer to Satellite Tracking of People, LLC, a      Delaware limited liability corporation having its principal place of      business at 1212 North Oak Road, Suite 100, Houston, Texas 77055, and its      Subsidiaries. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “MICHELLE” shall mean and refer to Michelle Enterprises, LLC, a      Florida limited liability company having its headquarters and principal      place of business at 19080 S.W. 44th      Street, Dunnellon, Florida, and its  Subsidiaries. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “RMDX” shall mean and refer to RemoteMDx, Inc., a Utah corporation      having its principal place of business at 150 West Civic Center Drive,      Suite 400, Salt Lake City, Utah 84070, and its    Subsidiaries. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “SecureAlert” shall mean and refer to SecureAlert, Inc., a Utah      corporation having its principal place of business at 150 West Civic      Center Drive, Suite 400, Salt Lake City, Utah, 84070, and its      Subsidiaries. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | The      term “the California Litigation” shall mean and refer to certain      litigation filed by RMDX against STOP in the Central District of      California, and captioned RemoteMDx, Inc. v. Satellite      Tracking of People, LLC, Civil Action CV 08-02899.  The      California Litigation asserts that STOP infringes U.S. Patent No.      7,330,122. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “the Texas Litigation” shall mean and refer to certain litigation      filed by STOP and MICHELLE against SecureAlert in the Eastern District of      Texas, and captioned Satellite Tracking of People,      LLC and Michelle Enterprises, LLC v. Pro Tech Monitoring, Inc., et al.,      Civil Action No. 2-08 CV-116.  The Texas Litigation      asserts that SecureAlert and others infringe U.S. Patent No. RE39,909      (“the ‘909 Patent”). |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “the ‘122 Patent” shall mean and refer to U.S. Patent No. 7,330,122,      owned by RMDX and asserted against STOP in the California      Litigation. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “the ‘909 Patent” shall mean and refer to U.S. Patent No. RE39,909,      licensed to STOP and owned byMICHELLE. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “Licensed STOP Patents” shall mean and refer to the ‘909 Patent, U.S.      Patent No. 6,774,797, and any U.S. patents issuing from U.S. Patent      Applications Serial Nos. 11/847,106 and 11/847,146, as well as all foreign      counterparts of said patents and all patents issuing from continuation,      divisional, reexamination, and reissue applications claiming priority to      such patents and patent applications. To the extent patents issue from      continuation-in-part applications claiming priority to the Licensed STOP      Patents and include claims that do not rely upon new matter that is      included for the first time in the continuation-in-part application, such      claims shall be included within the definition of “Licensed STOP      Patents.”  A list of all of STOP’s (i) United States and foreign      counterpart patent applications and (ii) United States and foreign      counterpart issued patents that fall within the definition of “Licensed      STOP Patents” is attached hereto as Exhibit C, and shall be updated by      STOP upon request by RMDX. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “STOP Carve-Outs” shall mean and refer to all U.S. patents (and      foreign counterparts) that issue from U.S. Patent Application Serial No.      12/576,090 (“the STOP ‘090 Application”) and U.S. Patent Application      Serial No. 12/576,054 (“the STOP ‘054 Application”) and/or from any      continuation, continuation-in-part, divisional, reexamination or reissue      application claiming priority to the STOP ‘090 or ‘054 Applications and      any reexamination or reissue thereof.  A list of all of STOP’s      (i) United States and foreign counterpart patent applications and (ii)      United States and foreign counterpart issued patents that fall within the      definition of “STOP Carve-Outs” is attached hereto as Exhibit D, and shall      be updated by STOP upon request byRMDX. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “STOP CNS Patents” shall mean all U.S. and foreign patents owned by      STOP or which STOP has the right to enforce as of the Effective Date of      this Agreement, and all patents, U.S. and foreign, that issue from      continuation, continuation-in-part, divisional, reissue or reexamination      applications claiming priority to those patents, but NOT including the      STOP Carve-Outs or the STOP Licensed Patents.  The STOP CNS      Patents shall also include all patents STOP acquires or obtains the right      to enforce during the term of the Covenant Not to Sue referenced in      section 7 of this Agreement.  Notwithstanding the foregoing,      U.S. Patent No. 6,405,213 ("the '213 Patent") and any reexamination or      reissues along with any and all foreign counterparts are not included in      the definition of STOP CNS Patents.  A list of all of STOP’s (i)      United States and foreign counterpart patent applications and (ii) United      States and foreign counterpart issued patents that fall within the      definition of “STOP CNS Patents” is attached hereto as Exhibit E, and      shall be updated by STOP upon request byRMDX. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Subject      to the carve-outs of section 1.15, the term “Licensed RMDX Patents” shall      mean and refer to the ‘122 Patent, U.S. Patent No. 7,545,318 B2, and any      U.S. patents issuing from U.S. Patent Application Serial No. 12/399,151,      as well as all foreign counterparts of said patents and all patents      issuing from continuation, divisional, reexamination, and reissue      applications claiming priority to such patents and patent applications. To      the extent patents issue from continuation-in-part applications claiming      priority to the Licensed RMDX Patents and include claims that do not rely      upon new matter that is included for the first time in the      continuation-in-part application, such claims shall be included within the      definition of “Licensed RMDX Patents.”  A list of all RMDX’s (i)      United States and foreign counterpart patent applications and (ii) United      States and foreign counterpart issued patents that fall within the      definition of “Licensed RMDX Patents” is attached hereto as Exhibit F, and      shall be updated by RMDX upon request bySTOP. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | The      term “RMDX Carve-Outs” shall mean and refer to claims 1-10 of the ‘122      Patent and any claims of future issued patents (domestic or foreign) owned      by RMDX or SecureAlert that recite two-way or more than two-way voice      communication between a locational tracking device and a remote monitoring      center, law enforcement/parole offices, or other offender-relevant third      parties, along with other elements.  The RMDX Carve-Outs shall      also include all claims of existing patents and patent applications      (domestic or foreign) listed on Exhibit G, which fall outside the Veridian      Fields of Use.  The RMDX Carve Outs shall also include all      claims of future patents and patent applications (domestic or foreign),      claiming priority to any patent or patent application listed on Exhibit G,      which fall outside the Veridian Fields of Use.  The RMDX      Carve-Outs shall not apply to the STOP BluFone device and any STOP future      device that provides voice communications as part of a separate unit (not      physically integrated into a single device) from the STOP BluTag or other      similar or replacement device.  A list of all RMDX’s (i) United      States and foreign counterpart patent applications and (ii) United States      and foreign counterpart issued patents that fall within the definition of      “RMDX Carve-Outs” is attached hereto as Exhibit G, and shall be updated by      RMDX upon request by STOP. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “Claims” shall mean and refer to any claims, cross-claims,      counterclaims, causes of action, liabilities, demands, obligations,      rights, damages, costs, or expenses of any nature, kind, or character that      have or could have been brought, asserted, alleged, or proposed in any      lawsuit, action, arbitration, or proceeding of any kind, nature, or      description, whether arising under or sounding in common law, contract,      tort, statute, regulation, or rule for any reason, with respect to any      dispute, controversy, or injury and for any amount or any form of      relief. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “RMDX CNS Patents” shall mean all U.S. and foreign patents owned by      RMDX or which RMDX has the right to enforce as of the Effective Date of      this Agreement, and all patents, U.S. and foreign, that issue from      continuation, continuation-in-part, divisional, reissue or reexamination      applications claiming priority to those patents, but NOT including the      RMDX Carve-Outs or the RMDX Licensed Patents.  The RMDX CNS      Patents shall also include all claims of existing patents and patent      applications (domestic or foreign) listed on Exhibit G, which fall within      the Veridian Fields of Use.  The RMDX CNS Patents shall also      include all claims of future patents and patent applications (domestic or      foreign), claiming priority to any patent or patent application listed on      Exhibit G, which fall within the Veridian Fields of Use.  The      RMDX CNS Patents shall also include all patents RMDX acquires or obtains      the right to enforce during the term of the Covenant Not to Sue referenced      in section 7 of this Agreement.  A list of all RMDX’s (i) United      States and foreign counterpart patent applications and (ii) United States      and foreign counterpart issued patents that fall within the definition of      “RMDX CNS Patents” is attached hereto as Exhibit H, and shall be updated      by RMDX upon request by STOP. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      term “Licensed Products” shall mean and refer to any products, systems,      methods or processes falling within the scope of one or more claims of the      Licensed STOP Patents, in the case of the license to RMDX, or the Licensed      RMDX Patents, in the case of the license to  STOP. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | For      purpose of calculating royalty obligations pursuant to this Agreement, the      term “License Base Revenues” shall mean and refer to revenues generated by      sales and other dispositions of Licensed Products      by RMDX and its Subsidiaries.  For the period from October 1,      2009 through September 30, 2012, License Base Revenues shall only      represent revenue from the sale and dispositions of Licensed Products that      exceed a cumulative total of $XXXXXXX in sales during that total period,      calculated in the fashion set forth in Exhibit I hereto.  For      all periods subsequent to September 30, 2012, License Base Revenues shall      include any and all revenues calculated in the fashion set forth in      Exhibit I hereto, regardless of the amounts calculated for periods prior      thereto.  The License Base Revenues shall be reported in RMDX’s      quarterly and annual SEC filings under a Segment Reporting note found in      “Notes to Condensed Consolidated Financial Statements.”  License      Base Revenues shall be subject to royalties, as set forth      hereinafter. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | The      term “Veridian Fields of Use” shall mean and refer to the following fields      of use, irrespective of whether uses in these fields now exist or arise in      the future: |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 1.1.1. | All      fields related to the tracking ofoffenders; |
|--------|--------|------------------------------------------------------|

|   | 1.1.2. | All      fields related to the use of tracking devices by or for law enforcement      agencies, including, without limitation, for the purpose of tracking      parolees, juvenile offenders, stolen property, gang members and gang      activities; victims and perpetrators,etc. |
|--------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 1.1.3. | All      fields related to the national defense of any country or governmental      subdivision, including, but not limited to applications used by defense      and intelligence gathering agencies |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 1.1.4. | All      fields related to terrorism and  counter-terrorism |
|--------|--------|-------------------------------------------------------------|

|   | The      term “Settlement Fee” shall mean the sum of $1,150,000 (One million,      one  hundred and fifty thousand and 00/100 dollars),      representing the guaranteed financial obligation of RMDX to STOP payable      during the first three years after October 1,  2009. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | “Party”      shall mean STOP, MICHELLE, RMDX or SecureAlert, as the case may      be. |
|--------|---------------------------------------------------------------------------------------------------|

| 2. | General      Purpose of Agreement The      purposes of the Parties in entering into this Agreement include, but are      not limited to, thefollowing: |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Resolve      the Texas and CaliforniaLitigations; |
|--------|---------------------------------------------------|

|   | Cross-license      the Licensed RMDX Patents and Licensed STOP Patents, pursuant to the terms      set forth in sections 3-6 hereof; |
|--------|--------------------------------------------------------------------------------------------------------------------------------------|

|   | Provide      a mechanism for RMDX and STOP to exchange patent rights so that each party      recovers the value of its respectively licensed patents and enjoys the      design freedom resulting from the authorized use of the other party's      licensed patents; and |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Provide      for a five-year period in which the Parties will be free from suit based      on the RMDX CNS Patents and STOP CNS Patents under the terms of a mutual      covenant not to sue. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | Grant of      Cross-Licenses |
|----|------------------------------|

|   | STOP      hereby grants to RMDX a non-exclusive license under the Licensed STOP      Patents to make, have made, use, sell, offer to sell and import Licensed      Products within the Veridian Fields.  This license does not      include any license to make, have made, use, sell, offer to sell and      import products or methods falling within the STOP      Carve-Outs.  The license shall be personal to RMDX, subject to      the provisions of this Agreement relating to sub-licensing of Subsidiaries      (section 3.5) and assignment      (section 18.1).  The license to RMDX shall be royalty bearing as      discussed in section 5below. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | RMDX      hereby grants to STOP a non-exclusive license under the Licensed RMDX      Patents to make, have made, use, sell, offer to sell and import Licensed      Products and related methods.  This license does not include any      license to make, have made, use, sell, offer to sell or import products or      methods falling      within the RMDX Carve-Outs.  The license shall be personal to      STOP, subject to the provisions of this Agreement relating to      sub-licensing of Subsidiaries (section 3.5) and assignment (section      18.1).  The license to STOP shall be fully paid up, based on the      offset and other consideration set forth in section 5      below. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Unless      earlier terminated for breach (subject to cure period), the license      granted to RMDX herein shall continue in effect until all of the claims of      the Licensed STOP Patents have (i) expired, or (ii) have been declared      invalid or unenforceable by the U.S. Patent and Trademark Office or a      court of competent jurisdiction and all appellate rights related thereto      have been exhausted or expired. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Unless      earlier terminated for breach (subject to cure period), the license      granted to STOP herein shall continue in effect until all of the claims of      the Licensed RMDX Patents have (i) expired, or (ii) have been declared      invalid or unenforceable by the U.S. Patent and Trademark Office or a      court of competent jurisdiction and all appellate rights related thereto      have been exhausted or expired. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      licenses granted herein include the right to grant sublicenses to      Subsidiaries who are Subsidiaries as of the Effective Date, and any such      sublicenses shall be retroactively effective as to such      Subsidiaries.  Any sublicense granted to an entity that becomes      a Subsidiary after the Effective Date shall be effective from the date of      grant, but shall have no effect on the liability of such a Subsidiary for      infringement occurring prior to the grant of the      sublicense.  Similarly, at such time as a Subsidiary ceases to      be a Subsidiary, any sublicense granted to it shall immediately      terminate.  Any sublicense granted under this Agreement shall      immediately terminate if the sublicensor's license is terminated pursuant      to the provisions of this Agreement.  Upon granting a      sublicense, a sublicensing Party shall promptly notify the other Party of      such sublicense in the manner provided for in this      Agreement.  Notwithstanding the foregoing, for purposes of this      section 3.5 only, Omnilink Systems, Inc. and Pro Tech Monitoring, Inc., or      any affiliates thereof, for so long as the Texas Litigation is pending      against Omnilink or Pro Tech (including any appeals, but in any case no      more than three (3) years from the Effective Date hereof), cannot qualify      as Subsidiaries of any Party to thisAgreement. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4. | Consideration to      RMDX |
|----|----------------------------|

|   | XXXXX |
|--------|-------|

----

| 5. | Consideration to      STOP |
|----|----------------------------|

|   | XXXXX |
|--------|-------|

|   | Settlement Fee:         The Settlement Fee set forth in this section 5.2      represents an irrevocable financial obligation payable by RMDX to STOP      under this Agreement.  The Settlement Fee is the net amount      payable in consideration of the dismissals of the Texas Litigation and the      California Litigation, and is an obligation of RMDX as of the Effective      Date, but shall be paid on the schedule provided for in this      Agreement. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| RMDX      Settlement Fee Schedule (Table)              |
|--------------------------------------------------------|
|                                                   |   |   |
| Term      Periods                                      | Annual      Payment | Quarterly      Payment |
| QE      12-31-09 through QE 09/30/10                   | $XXXXXXXXX | $XXXXXXXXXXX |
| QE      12-31-10 through QE 09/30/11                   | $XXXXXXXXX | $XXXXXXXXXXX |
| QE      12-31-11 through QE 09/30/12                   | $XXXXXXXXX | $XXXXXXXXXXX |
|    Total      Settlement Fee Obligation | $XXXXXXXXX |   |
|                                                   |   |   |
| Quarterly Payment      Schedule                        | Payment Due      Date |   |
| Quarters      Ending 12/31                             | March      1st |   |
| Quarters      Ending 3/31                              | June      1st |   |
| Quarters      Ending 6/30                              | September      1st |   |
| Fiscal      Year Ending 9/30                           | December      1st |   |
|                                                   |   |   |

----

|   | 5.1.1. | The      Rolling Advance shall be maintained at an amount which is the greater of      any quarterly Settlement Fee then owed and the adjusted Rolling Advance      calculated pursuant to section 5.4.3below. |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 5.1.2. | The      first rolling advance payment (“the First Rolling Advance”) is due within      five (5) business days of the Effective Date, and shall be in the amount      of $XXXXX. |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 5.1.3. | At      the end of the quarter in which RMDX realizes License Base Revenues, the      Rolling Advance will be calculated to determine whether such needs to be      increased or decreased based upon the royalties actually due, and paid,      for that quarter.  If the royalties based on actual sales totals      for that quarter exceed the then Rolling Advance, RMDX shall remit such      excess with the next quarterly royalty payment to be held as part of the      Rolling Advance.  If, on the other hand, the then Rolling      Advance exceeds the royalties actually due for the quarter, such excess      shall apply as a credit against the next quarter’s royalty payment and the      Rolling Advance shall be adjusted downwardly  accordingly. |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 6. | Adjustment of      Royalty |
|----|----------------------------|

|   | XXXXX |
|--------|-------|

| 7. | Covenant Not to      Sue |
|----|--------------------------|

----

|   | Subject      to the termination provisions of section 13, STOP shall not sue RMDX for      infringement of the STOP CNS Patents for a period of five (5) years from      the Effective Date ("the five-yearperiod"). |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Subject      to the termination provisions of section 13, RMDX shall not sue STOP for      infringement of the RMDX CNS Patents during the five-year      period. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | A      party's covenant not to sue the other party shall immediately terminate      during the five-year period upon a covenanting party's termination of its      licenses to the other party pursuant to the provisions of section 13 of      this Agreement.  Accordingly, if STOP terminates its license      grant set forth in section 3.1, its covenant not to sue, as set forth in      section 7.1, shall also terminate.  Similarly, if RMDX      terminates its license grant, as set forth in section 3.2, its covenant      not to sue set forth in section 7.2 shall also  terminate. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      covenants not to sue granted herein do not include a covenant not to sue      with respect to the STOP Carve-Outs or the RMDX  Carve-Outs. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      covenants not to sue granted herein include a covenant not to sue      Subsidiaries of the Parties to this Agreement who are Subsidiaries as of      the Effective Date.  For Subsidiaries who become Subsidiaries      after the Effective Date, the covenants not to sue are effective only on a      prospective basis, and shall have no effect on liability of such a      Subsidiary for infringement occurring prior to its becoming a      Subsidiary.  Similarly, at such time as a Subsidiary ceases to      be a Subsidiary, the covenants not to sue granted herein shall immediately      terminate as to that entity. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Upon      the expiration or termination of the covenants not to sue granted herein,      STOP and RMDX shall be free to bring actions for infringement of their      respective CNS Patents, but only for damages accruing after the expiration      or termination of the five-year period of the covenant not to      sue. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | No      action for infringement of the STOP CNS Patents or RMDX CNS Patents shall      be brought against any Party to this Agreement upon the expiration or      termination of the covenants not to sue granted herein, unless and until      the following procedure has beencompleted: |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 7.1.1. | Any      Party believing that another Party is infringing one or more claims of a      CNS Patent after the expiration or termination of the five-year covenant      not to sue granted herein shall notify in writing the Party it believes is      infringing, and inform that Party of its belief that infringement is      occurring. |
|--------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 7.1.2. | The      Parties shall thereafter engage in good-faith negotiations for a period of      not less than four (4) months in an attempt to resolve the claim of      infringement. |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 7.1.3. | If      the Parties are unable to resolve the claim of infringement by      negotiation, the Party asserting infringement may thereafter bring an      action against the other. |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 7.1.4. | This      section 7.7 shall not be construed to require any Party to grant a license      to another Party upon the expiration of the covenant not to      sue. |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 7.1.5. | Neither      the notice of infringement required by this section 7.7 nor any statements      made in the course of the negotiations required by this section 7.7 may be      asserted as a basis for a claim for declaratory      judgment.  Similarly, no statement made in the notice or the      negotiations required by this section may be used in any subsequent      litigation involving the STOP or RMDX CNS  Patents. |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | 7.1.6. | If      infringement of a CNS Patent occurs during the four-month negotiation      period referenced in this section 7.7, and the Parties are not able to      come to agreement as to a resolution of that infringement, damages for      infringement are not waived for the four-month period in which      negotiations proceeded. |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 8. | Most Favored      Nations |
|----|---------------------------|

|   | XXXXX |   |
|--------|-------|--------|

| 9. | Audit |
|----|-------|

|   | STOP      shall have the right to have its independent auditors make an audit,      during normal business hours and upon reasonable notice, of all records      and accounts of RMDX and its Subsidiaries that bear upon the calculation      of License Base Revenues.  Such audits shall occur not more than      once per calendar year.  STOP shall pay the cost of such audit      unless the audit reveals discrepancies showing underpayments greater than      10% of those owed under this Agreement.  If such discrepancies      occur, RMDX shall pay the cost of theaudit. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 10. | Disposition of Texas      and California Litigations |
|-----|------------------------------------------------------|

|   | STOP      and RMDX shall execute a stipulation for dismissal in the form set forth      in Exhibit A hereto.  Within five (5) business days of the      execution of this Agreement, RMDX shall file such stipulation for      dismissal in the California Litigation.  The Parties shall file      an order of dismissal with the Court in California in the form attached      hereto as Exhibit J. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | STOP,      MICHELLE and SecureAlert shall execute a stipulation for dismissal in the      form set forth in Exhibit B hereto.  Within five (5) business      days of the execution of this Agreement, STOP and MICHELLE shall file such      stipulation for dismissal in the Texas Litigation.  The Parties      shall file an order of dismissal with the Court in Texas in the form      attached hereto as Exhibit K. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | As      soon as possible after the filing of the stipulation for dismissal      referenced in section 10.2 hereof, but not later than 3 business days      after such filing, SecureAlert and RMDX shall withdraw from any joint      defense or community of interest arrangement it may have with respect to      the ‘909 patent and the Texas Litigation.  Notwithstanding the 3      day maximum time period for withdrawal, immediately upon execution of this      Agreement by all Parties hereto, RMDX shall cease all participation in any      joint defense or community of interest  agreement. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 11. | Agreement not to      Contest Licensed and CNSPatents |
|-----|-------------------------------------------------------|

|   | STOP      agrees that it will not, during the existence of the license granted by      RMDX herein, file any litigation, reexamination, reissue, protest or other      similar proceeding, in any U.S. or foreign court or in the United States      Patent and Trademark Office or foreign patent office contesting the      validity or enforceability of any of the RMDX Licensed Patents, or assert      or develop any defense or legal challenge to such patents, or assist any      third party in asserting or developing any defense or other legal      challenge to the RMDX LicensedPatents. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | During      the term of the Covenant Not to Sue, STOP agrees that it will not file any      litigation, reexamination, reissue, protest or other proceeding, in any      U.S. or foreign court or in the United States Patent and Trademark Office      or foreign patent office contesting the validity or enforceability of any      of the RMDX CNS Patents, or assert or develop any defense or legal      challenge to such patents, or assist any third party in asserting or      developing any defense or other legal challenge to the RMDX CNS      Patents. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | RMDX      agrees that it will not, during the existence of the license granted by      STOP herein, file any litigation, reexamination, reissue, protest or other      proceeding, in any U.S. or foreign court or in the United States Patent      and Trademark Office or foreign patent office contesting the validity or      enforceability of any of the STOP Licensed Patents, or assert or develop      any defense or legal challenge to such patents, or assist any third party      in asserting or developing any defense or other legal challenge to the      STOP Licensed Patents. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | During      the term of the Covenant Not to Sue, RMDX agrees that it will not file any      litigation, reexamination, reissue, protest or other proceeding, in any      U.S. or foreign court or in the United States Patent and Trademark Office      or foreign patent office contesting the validity or enforceability of any      of the STOP CNS Patents, or assert or develop any defense or legal      challenge to such patents or assist any third party in asserting or      developing any defense or other legal challenge to the STOP CNS      Patents. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | RMDX      warrants that it has not, prior to the Effective Date, filed or had any      involvement in any reexamination or reissue proceeding with respect to any      Licensed STOP Patent or STOP CNS Patent, except with respect to      reexamination proceeding currently pending for the ‘909 patent and the      reissue proceeding pending with respect to STOP’s ‘481    patent. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | STOP      warrants that it has not, prior to the Effective Date, filed or had any      involvement in any reexamination or reissue proceeding with respect to any      Licensed RMDX Patent or RMDX CNSPatent. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Each      Party represents and warrants to the other that it has not formed or      acquired any company that meets the definition of Subsidiary between      October 1, 2009 and the Effective Date.  The parties shall list      all Subsidiaries as of the Effective Date on Exhibit  L. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The      provisions of section 11 shall apply to any present or future Subsidiary      of STOP and RMDX to the same extent as they apply to STOP and      RMDX. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 12. | Releases |
|-----|----------|

|   | STOP      hereby releases and forever discharges RMDX and all of its Subsidiaries      who are Subsidiaries as of the Effective Date, along with their respective      past and present principals, directors, officers, agents, employees,      shareholders, and customers (hereinafter collectively, "released parties")      from and against all Claims (including, but not limited to, Claims      asserted in the Texas Litigation or that otherwise could have been brought      or asserted in such litigation), whether known or unknown, existing or      potential, or suspected or unsuspected, which STOP had or asserted or      could have asserted, has or asserts or could assert, or may hereafter have      or assert against RMDX and SecureAlert and all of their present      Subsidiaries.  This release shall not operate to release      competitors of STOP who are not Subsidiaries of RMDX as of the Effective      Date.  This release shall be effective only as to Claims arising      prior to the Effective Date. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | MICHELLE      hereby releases and forever discharges RMDX and all of its Subsidiaries      who are Subsidiaries as of the Effective Date, along with their respective      past and present principals, directors, officers, agents, employees,      shareholders, and customers (hereinafter collectively, "released parties")      from and against all actions, claims, suits, demands, damages, judgments,      causes of action, debts, liabilities, promises, or controversies of any      kind whatsoever, whether presently known or unknown, that MICHELLE alone      or along with STOP has or had or may have against any such released      parties arising from the Texas Litigation or arising or claimed to arise      out of any infringement or asserted infringement of the '909 Patent.  This      release shall not operate to release any competitors of MICHELLE who are      not Subsidiaries of RMDX as of the Effective Date.  This release      shall be effective only as to Claims arising prior to the Effective      Date. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | RMDX      and Secure Alert hereby release and forever discharge STOP and all of its      Subsidiaries who are Subsidiaries as of the Effective Date, along with      their respective past and present principals, directors, officers,      agents,  employees, and shareholders, and customers (hereinafter      collectively, "released parties") from and against all Claims (including,      but not limited to, those Claims asserted in the California Litigation or      that otherwise could have been brought or asserted in such litigation),      whether known or unknown, existing or potential, or suspected or      unsuspected, which RMDX or Secure Alert had or asserted or could have      asserted, has or asserts or could assert, or may hereafter have or assert      against STOP and all of its present Subsidiaries.  This release      shall not operate as a release of competitors of RMDX or Secure Alert who      are not Subsidiaries of STOP as of the Effective Date.  This      release shall be effective only as to Claims arising prior to the      Effective Date |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13. | Termination |
|-----|-------------|

|   | In      the event of a material breach of this Agreement, the non-breaching Party      may, in addition to any other remedies it may have, terminate the license      granted by it in section 3 hereof to any breaching Party by giving not      less than 120 days written notice of the alleged breach, specifying the      nature of the breach.  The party alleged to be in breach shall      have a period of 120 days after receipt of notice to cure any alleged      breach.  If cure occurs within said 120-day period, the notice      of breach shall be ineffective.  The non-breaching Party's      termination of its license to the breaching Party shall also automatically      and at the same time terminate (i) any and all sublicenses granted by the      breaching Party and (ii) the covenant not to sue extended by the      non-breaching Party to the breaching Party and as applicable to any of the      breaching Party's Subsidiaries. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | Notwithstanding      the termination of the rights of a breaching Party hereunder, the      non-breaching Party shall continue to have the benefit of its license and      the covenant not to sue as respectively set forth in sections 3 and 7 of      this Agreement. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 14. | Press Release, Other      Disclosure andConfidentiality |
|-----|---------------------------------------------------------|

|   | The      Parties shall agree upon and issue a joint press release within five (5)      business days hereof.  Other than the express terms of the press      release, the Parties agree that the terms of this Agreement are      confidential and shall not be disclosed to any third party for any      purpose, except to the extent that a Party is required to disclose the      terms of this Agreement by the Securities and Exchange Commission, GAAP or      other applicable governmental authority and, in such case, only the terms      of this Agreement shall be disclosed.  In the event such      disclosure contains more than the recitation of all or a portion of the      terms of this Agreement, then the entire disclosure must be approved in      writing by the Parties prior to itsdisclosure. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Notwithstanding      the foregoing, STOP shall have the right, in its sole discretion, to use      and disclose this Agreement, a) in the ‘909 Patent reexamination, redacted      to disclose only that i) RMDX and SecureAlert have taken a license under      the ‘909 Patent, ii) RMDX and SecureAlert will pay STOP for such license      rights, and iii) RMDX and SecureAlert have stipulated that the claims of      the ‘909 Patent are valid and enforceable; and b) in the Texas Litigation,      including all of its terms and conditions, provided that STOP takes steps      to protect its confidentiality, including, but not limited to, production      as “Confidential” under the terms of the Protective Order in the Texas      Litigation, and filing any documents containing this Agreement or making      reference to its terms in the Texas Litigation under seal.  In      any case, STOP shall be permitted to use and disclose this Agreement as      part of any trial in the TexasLitigation. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15. | Warranties |
|-----|------------|

|   | STOP      warrants that it owns all right, title and interest in and to Licensed      STOP Patents 6,774,797, 11/847,106, 11/847,146, and all foreign      counterparts thereof as listed on Exhibit C; and to STOP CNS Patents      6,703,936, 6,992,582, 7,619,513, and all foreign counterparts thereof as      listed on Exhibit E; and is authorized to grant the license, release and      covenant not to sue granted herein, except as set forth in section 15.3      below. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Michelle      warrants that it owns all right, title and interest in and to Licensed      STOP Patents RE 39,909 and 11/806,841, and to STOP CNS Patents 5,867,103;      6,160,481; 6,218,945; 6,512,456; and RE 38,838; and is authorized to grant      the license, release and covenant not to sue granted    herein. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | STOP      does not warrant that it owns title to the ‘909 Patent, but warrants and      represents that it has the absolute and unfettered right to grant the      license and release granted herein with respect to the ‘909      Patent.  STOP further agrees to indemnify and hold RMDX harmless      from any and all claims by MICHELLE and/or any third party for      infringement of the ‘909 Patent, provided such claims arise from STOP's      breach of its exclusive license agreement with MICHELLE with respect to      the '909 Patent.  Such indemnity shall include indemnity for any      award or settlement RMDX is required to pay for infringement of the ‘909      Patent, as well as all attorneys’ fees and costs associated      therewith. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | RMDX      warrants that it owns all right, title and interest in and to the ‘122      Patent, the Licensed RMDX Patents and RMDX CNS Patents and is authorized      to grant the license, release and covenant not to sue granted      herein. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | Each      Party hereto represents and warrants that it has not transferred, assigned      or otherwise alienated any of the Claims released herein prior to the      Effective Date. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Each      Party hereto represents and warrants that the execution of this Agreement      and the covenants herein are within its authority and that this Agreement      is executed pursuant to necessary and customary      authorizations. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 16. | Notice |
|-----|--------|

|   | Any      Notice required under this Agreement shall be in writing, sent by      certified or registered mail, addressed and served as    follows: |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------|

| 17. | Stipulations of      Validity and Infringement |
|-----|------------------------------------------------|

|   | STOP      hereby stipulates that the claims of the ‘122 Patent are valid,      enforceable and infringed by the BluTag device and related system software      and use of same. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | RMDX      hereby stipulates that the claims of the ‘909 Patent are valid,      enforceable and infringed by the TrackerPal I and II devices and related      system software and use of same. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 18. | Assignment or      Transfer |
|-----|-----------------------------|

|   | Subject      to the provisions of section 3.5 above, the licenses and rights granted      hereunder shall not be transferable or assignable by the licensed party,      except to a third party that acquires all or substantially all of the      business of the licensed Party, provided that the licensing Party has not,      as of the effective date of the transfer, commenced any action against the      proposed assignee for infringement of any patent or patents that are      licensed under the license being transferred or assigned.  For      the purpose of section 18.1, patent or patents which are licensed by STOP      include those in the definition of Licensed STOP Patents or STOP CNS      Patents, and with respect to RMDX, includes any patent or patents which      are licensed by RMDX that include those in the definition of Licensed RMDX      Patents or RMDX CNS patents. The restrictions on transfer of the STOP      and RMDX CNS patents shall expire with the expiration or termination of      the covenants not to sue of section 7 hereof. Any transfer or      assignment of licenses or rights granted hereunder shall not operate to      relieve the transferee of any liability for infringement arising prior to      the date of assignment or transfer.  Further, any assignment or      transfer not specifically prohibited above, shall require the written      consent of the licensing Party, such consent not to be unreasonably      withheld. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 19. | Miscellaneous |
|-----|---------------|

----

----

| STOP                                                                                                                                                                                                                                                                                                   |   | MICHELLE      ENTERPRISES, LLC                                                                                                                                                                                                                                                                                                                                                       |   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|                                                                                                                                                                                                                                                                                                   |   | (signs      below to indicate its consent to this Settlement Agreement and its      obligations under sections 10.2, 12.2 and 15.2.)                                                                                                                                                                                                                                                 |   |
|                                                                                                                                                                                                                                                                                                   |   |                                                                                                                                                                                                                                                                                                                                                                                 |   |
| By:/s/ Steve      Logan                                                                                                      |   | By:/s/ Diana      Taylor                                                                                                                                                                         |   |
| Its:CEO                                                                                        |   | Its:      President                                                                                                                       |   |
|                                                                                                                                                                                                                                                                                                   |   |                                                                                                                                                                                                                                                                                                                                                                                 |   |
| RMDX                                                                                                                                                                                                                                                                                                   |   | SECUREALERT                                                                                                                                                                                                                                                                                                                                                                          |   |
| By:/s/ John L. Hastings,      III                                                                                                                                                             |   | By:/s/ John L. Hastings,      III                                                                                                                                                                          |   |
| Its      President                                               |   | Its      President                                                            |   |

----

| REMOTEMDx,      INC., Plaintiff andCounterdefendant, v. SATELLITE      TRACKING OFPEOPLE,      L.L.C., aka STOP,LLC, Defendant andCounterclaimant.  | Case      No. CV-08-02899 ODW (FMOx)  STIPULATION      FOR DISMISSAL OF CLAIMS AND COUNTERCLAIMS WITH PREJUDICE Assigned      to the HonorableOtis      D. Wright, II    |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| DATED:  January      29, 2010 | Respectfully      submitted,                                                             |   |
|-----------------------------------------|------------------------------------------------------------------------------------------|--------|
|                                    |                                                                                     |   |
|                                    | Workman      | Nydegger                                                                  |   |
|                                    |                                                                                     |   |
|                                    | By /s/      Brent P. Lorimer                                                             |   |
|                                    |                  Brent P. Lorimer |   |
|                                    |                                                                                     |   |
|                                    | Attorneys      for Plaintiff RemoteMDx, Inc.                                             |   |
|                                    |                                                                                     |   |
|                                    | GIBBONS      P.C.                                                                        |   |
|                                    |                                                                                     |   |
|                                    |                                                                                     |   |
|                                    | By /s/      Thomas J. Vetter                                                             |   |
|                                    |                  Thomas J. Vetter |   |
|                                    |                                                                                     |   |
|                                    | Attorney      for Defendant Satellite                                                    |   |
|                                    | Tracking      of People, L.L.C.                                                          |   |

----

|   |                      |   |
|--------|---------------------------|--------|
|   | /s/      Brent P. Lorimer |   |
|   |                      |   |

----

| SATELLITE      TRACKING OF PEOPLE, LLC (a/k/a STOP, LLC) and MICHELLE ENTERPRISES,      LLC, Plaintiff, v. PRO      TECH MONITORING, INC., OMNILINK SYSTEMS, INC., and SECUREALERT,      INC., Defendants. |   | )))))))))))))  |   CASE      NO. 2:08-CV-116 (CE)            JURY      TRIAL DEMANDED    |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

----

| Patent      Number | Issue      Date       | Title                                                                                     |
|--------------------|-----------------------|------------------------------------------------------------------------------------------------|
| RE      39,909     | November      6, 2007 | Tracking      system for locational tracking of monitored persons                              |
| 6,774,797          | August      10, 2004  | Wireless      tag and monitoring center system for tracking the activities of      individuals |

| Application      Number | Filing      Date     | Title                                                                                                            |
|-------------------------|----------------------|-----------------------------------------------------------------------------------------------------------------------|
| 11/847,106         | August      29, 2007 | Active      wireless tag and auxiliary device for use with monitoring center for      tracking individuals or objects |
| 11/847,146         | August      29, 2007 | Wireless      tag and auxiliary device for use with home monitoring unit for tracking      individuals or objects     |
| 11/806,841              | June      4, 2007    | Monitoring      system                                                                                           |

| Corresponding      United States Patent or Application Number | Foreign      Application Number | Foreign      Filing Date | Foreign      Application Title                                                                                   |
|---------------------------------------------------------------|---------------------------------|--------------------------|-----------------------------------------------------------------------------------------------------------------------|
| 6,774,797                                                     | EP      1363258 (A1)            | May      12, 2003        | Wireless      tag and monitoring center system for tracking the activities of      individuals                        |
| 11/847,106                                                    | CA      2,661,910          | August      29, 2007     | Active      wireless tag and auxiliary device for use with monitoring center for      tracking individuals or objects |
| 11/847,106                                                    | UK      GB 0903439.8       | August      29, 2007     | Active      wireless tag and auxiliary device for use with monitoring center for      tracking individuals or objects |
| 11/847,146                                                    | CA      2,662,023               | August      29, 2007     | Wireless      tag and auxiliary device for use with home monitoring unit for tracking      individuals or objects     |
| 11/847,146                                                    | UK      GB 0903440.6            | August      29, 2007     | Wireless      tag and auxiliary device for use with home monitoring unit for tracking      individuals or objects     |
| 11/847,146                                                    | Hong      Kong 09111371.7       | August      29, 2007     | Wireless      tag and auxiliary device for use with home monitoring unit for tracking      individuals or objects     |

----

| Application      Number | Filing      Date     | Title                                                                                 |
|-------------------------|----------------------|---------------------------------------------------------------------------------------|
| 12/576,090              | October      8, 2009 | Technique      for detecting tracking device tampering using an auxiliary      device |
| 12/576,054              | October      8, 2009 | Technique      for detecting tracking devicetampering                                 |

| Corresponding      United States Patent or Application Number | Foreign      Application Number | Foreign      Filing Date | Foreign      Application Title                        |
|---------------------------------------------------------------|---------------------------------|--------------------------|-------------------------------------------------------|
| 12/576,054                                                    | CA      2,682,072               | October      10, 2009    | Technique      for detecting tracking devicetampering |

----

| Patent      Number | Issue      Date        | Title      of Patent                                        |
|--------------------|------------------------|-------------------------------------------------------------|
| 5,867,103          | February      2, 1999  | Monitored      Person Tracking System                       |
| 6,160,481          | December      12, 2000 | Monitoring      System                                      |
| 6,218,945          | April      17, 2001    | Augmented      Monitoring System                            |
| 6,512,456          | January      28, 2003  | Mobile      Medical Monitoring Device                       |
| 6,703,936          | March      9, 2004     | System      and method for tracking movement of individuals |
| RE      38,838     | October      18, 2005  | Monitoring      System                                      |
| 6,992,582          | January      31, 2006  | System      and method for tracking movement of individuals |
| 7,619,513          | November      17, 2009 | System      and method for tracking movement ofindividuals  |

| Corresponding      United States Patent or Application Number | Foreign      Application Number | Foreign      Filing Date | Foreign      Application Title                              |
|---------------------------------------------------------------|---------------------------------|--------------------------|-------------------------------------------------------------|
| 6,703,936                                                     | EP      1433145 (A1)       | September      26, 2002  | System      and method for tracking movement of individuals |
| 6,703,936                                                     | CA      2461837 (A1)            | September      26, 2002  | System      and method for tracking movement ofindividuals  |

----

| Title                                                                                                                      | Application      No. | Patent/      Registration No. |
|----------------------------------------------------------------------------------------------------------------------------|----------------------|-------------------------------|
| Remote      Tracking and Communication Device                                                                              | 11/202427            | 7330122*                      |
| Remote      Tracking and Communications Device                                                                             | 12/028088            |  Pending*                |
| Remote      Tracking System and Device With Variable Sampling and Sending Capabilities      Based on Environmental Factors | 11/486991            | 7545318                       |
| A      System and Method for Monitoring Individuals Using a Beacon and      Intelligent Remote Tracking Device             | 12/399151            |  Pending*                |

| Title                                                                                                                | Application      No. |
|----------------------------------------------------------------------------------------------------------------------|----------------------|
| Remote      Tracking and Communication Device - EPO                                                                  | 06836098.1*          |
| Remote      Tracking and Communication Device - Brazil                                                               | PI0614742.9*         |
| Remote      Tracking and Communication Device - Canada                                                               | 2617923*             |
| Remote      Tracking and Communication Device - Mexico                                                               | MX/a/2008/001932*    |
| A      System and Method for Monitoring Individuals Using a Beacon and      Intelligent Remote Tracking Device - PCT | PCT/US2009/036335*   |

| * | The      license of this patent or patent application is limited to issued claims      that do not fall within the definition of RMDX Carve-Outs, as defined in      section 1.15 of the Settlement Agreement between the    parties. |
|---|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Title                                                                                                                                 | Application      No. | Patent/      Registration No. |
|---------------------------------------------------------------------------------------------------------------------------------------|----------------------|-------------------------------|
| PANIC      BUTTON PHONE                                                                                                               | 09/044497            | 6044257*                      |
| Emergency      Phone with Single-Button Activation                                                                                    | 09/538364            | 6636732*                      |
| Emergency      Phone With Alternate Number Calling Capability                                                                         | 09/684831            | 7092695*                      |
| Emergency      Phone with Single-Button Activation                                                                                    | 11/174191            | 7251471*                      |
| Emergency      Phone With Single Button Activation                                                                                    | 11/830398            | Pending *                |
| Emergency      Phone for Automatically Summoning Multiple Emergency Response      Services                                            | 09/173645            | 6226510*                      |
| COMBINATION      EMERGENCY PHONE AND PERSONAL AUDIO DEVICE                                                                            | 09/185191            | 6285867*                      |
| Remote      Tracking and Communication Device                                                                                         | 11/202427            | 7330122*                      |
| Remote      Tracking and Communications Device                                                                                        | 12/028088            |  Pending*                |
| ALARM      AND ALARM MANAGEMENT SYSTEM FOR REMOTE TRACKING DEVICES                                                                    | 11/486992            |  Pending*                |
| A      Remote Tracking Device and a System and Method for Two-Way Voice      Communication Between the Device and a Monitoring Center | 11/486989            |  Pending*                |
| A      Remote Tracking System with a Dedicated Monitoring Center                                                                      | 11/486976            |  Pending*                |

----

| Title                                                                       | Application      No. | Patent/      Registration No. |
|-----------------------------------------------------------------------------|----------------------|-------------------------------|
| Emergency      Phone with Single-Button Activation - Japan                  | 2001-571568          |  Pending*                |
| Emergency      Phone with Single-Button Activation - China                  | 01807350.6           | 01807350.6*Pending            |
| A      Remote Tracking System with a Dedicated Monitoring Center -      EPO | 07812596.0           |  Pending*                |
| A      Remote Tracking System with a Dedicated Monitoring Center - Brazil   | PI0714367.2          |  Pending*                |
| Remote      Tracking and Communication Device - EPO                         | 06836098.1           |  Pending*                |
| Remote      Tracking and Communication Device - Brazil                      | PI0614742.9          |  Pending*                |
| Remote      Tracking and Communication Device - Canada                      | 2617923              |  Pending*                |
| Remote      Tracking and Communication Device - Mexico                      | MX/a/2008/001932     |  Pending*                |

| * | The      Carve-Outs for this patent or patent application are limited to issued      claims that do fall within the definition of RMDX Carve-Outs, as defined      in section 1.15 of the Settlement Agreement between the      parties. |
|---|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Title                                                                                                                                 | Application      No. | Patent/      Registration No. |
|---------------------------------------------------------------------------------------------------------------------------------------|----------------------|-------------------------------|
| REMOTELY      CONTROLLABLE THERMOSTAT                                                                                                 | 09/513110            | 6260765                       |
| INTERFERENCE      STRUCTURE FOR EMERGENCY RESPONSE SYSTEM WRISTWATCH                                                                  | 09/651523            | 6366538                       |
| PANIC      BUTTON PHONE                                                                                                               | 09/044497            | 6044257*                      |
| Emergency      Phone with Single-Button Activation                                                                                    | 09/538364            | 6636732*                      |
| Emergency      Phone With Alternate Number Calling Capability                                                                         | 09/684831            | 7092695*                      |
| Emergency      Phone with Single-Button Activation                                                                                    | 11/174191            | 7251471*                      |
| Emergency      Phone With Single Button Activation                                                                                    | 11/830398            | Pending *                |
| Emergency      Phone for Automatically Summoning Multiple Emergency Response      Services                                            | 09/173645            | 6226510*                      |
| COMBINATION      EMERGENCY PHONE AND PERSONAL AUDIO DEVICE                                                                            | 09/185191            | 6285867*                      |
| ALARM      AND ALARM MANAGEMENT SYSTEM FOR REMOTE TRACKING DEVICES                                                                    | 11/486992            |  Pending*                |
| A      Remote Tracking Device and a System and Method for Two-Way Voice      Communication Between the Device and a Monitoring Center | 11/486989            |  Pending*                |
| A      Remote Tracking System with a Dedicated Monitoring Center                                                                      | 11/486976            |  Pending*                |

----

| Title                                                                       | Application      No. | Patent/      Registration No. |
|-----------------------------------------------------------------------------|----------------------|-------------------------------|
| A      Remote Tracking System with a Dedicated Monitoring Center -      EPO | 07812596.0           |  Pending*                |
| A      Remote Tracking System with a Dedicated Monitoring Center - Brazil   | PI0714367.2          |  Pending*                |
| Emergency      Phone with Single-Button Activation - Japan                  | 2001-571568          |  Pending*                |
| Emergency      Phone with Single-Button Activation - China                  | 01807350.6           | 01807350.6*                   |

| * | The      inclusion of this patent or patent application as an RMDX CNS Patent is      limited to issued claims that do not fall within the definition of RMDX      Carve-Outs, as defined in section 1.15 of the Settlement Agreement between      the parties. |
|---|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 1. | License      Base Revenues    Subject      to the provisions of sections 2 and 3 below, License Base Revenues shall      consist of any and all revenues realized by RMDX and its Subsidiaries from      the use, sale, importation, lease, distribution or furnishing of any of      the following: |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 1.1. | Revenues      from any activated locational tracking device that utilizes GPS to      determine its location and is supported entirely about a single limb of      the monitored person, regardless of brand or manufacturer (hereinafter the      “One Piece Tracking Device”). |
|--------|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 1.2. | Revenues      from any accessory related to a One Piece Tracking Device, including but      not limited to related, interactive beacons and victim      devices. |
|--------|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 1.3. | Revenues      from locational tracking database services related to a One Piece Tracking      Device in section 1.1 or accessory in section  1.2. |
|--------|------|---------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 1.4. | If      License Base Revenues are realized from RMDX or SecureAlert Contracts with      independent third parties, such License Base Revenues shall be the per      diem rate for each activated covered unit per day, as reflected in the      respective contract, provided that the resulting royalty is not less than      the minimum per day royalty per activated covered unit required by the      Settlement Agreement. |
|--------|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 1.5. | If      License Base Revenues are realized by RMDX through intercompany transfers      or charges, such License Base Revenues shall be the greater of (i) $XXXXX      per activated covered unit per day, or (ii) the actual contractual      intercompany charge to that subsidiary related to each individual device,      but not less than minimum per day royalty per activated covered unit      required by the SettlementAgreement. |
|--------|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2.1. | Revenues      from any devices, accessories and services not falling within section 1      above. |
|--------|------|---------------------------------------------------------------------------------------------------|

|   | 2.2. | Revenues      from idle One Piece Tracking Devices provided the per day revenue      therefrom is less than $XXXXX. |
|--------|------|---------------------------------------------------------------------------------------------------------------------|

|   | 2.3. | Revenues      from non-GPS devices not related to GPS device deployment described above      (e.g. AMS - SCRAM units, drug or alcohol  devices). |
|--------|------|--------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | 2.4. | Revenues      from non-GPS related House Arrest devices, wherein the device worn by the      person does not have a GPSreceiver. |
|--------|------|----------------------------------------------------------------------------------------------------------------------------------|

|   | 2.5. | Revenues      from non-offender – exclusively consumer based services (home security,      healthcare, Personal Emergency Response Systems,  etc.). |
|--------|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2.6. | Revenues      from private probation, case management and related services, subject to      section 3 below. |
|--------|------|--------------------------------------------------------------------------------------------------------------|

|   | 2.7. | Revenues      from all other products or services, which are unrelated to GPS device      deployments on a single limb and/or for auxiliary support devices/services      related thereto. |
|--------|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2.8. | Revenues      related to lost or stolen devices, and itemized billings for: freight      and/or shipping charges, applicable federal, state and local sales and use      taxes, insurance, customs and exportduties. |
|--------|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2.9. | Revenues      from any devices solely used to track inanimate  objects. |
|--------|------|-------------------------------------------------------------------------|

| 3. | Treatment of License      Base Revenues Mixed With Revenues From Private Probation, Case Management      and Related Services |
|----|-------------------------------------------------------------------------------------------------------------------------------|

|   | 3.1. | The      parties acknowledge that RMDX may provide private probation, case      management or related services in conjunction with products or services      that generate License Base Revenues.  The parties further      acknowledge that the contracts for such services may, or may not, include      an express allocation of value to License Base  Revenues. |
|--------|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3.2. | When      RMDX provides private probation, case management or related services      (“Probation and Case Management Services”) in conjunction with products or      services that generate License Base Revenues, License Base Revenues shall      be calculated as follows: |
|--------|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3.2.1. | If      an applicable contract expressly allocates percentages or dollar values      between Probation and Case Management Services and  License Base      Revenues, License Base Revenues shall include the greater of the express      allocation to License Base Revenues or be deemed to include revenues in an      amount sufficient to produce a royalty not less than the minimum per      covered activated unit per day royalty provided for in the Settlement      Agreement. |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | 3.2.2. | If      the applicable contract does not expressly allocate percentages or dollar      values between Probation and Case Management Services      and  License Base Revenues, License Base Revenues shall be      deemed to include revenues in an amount sufficient to produce a royalty      not less than the minimum per covered activated unit per day royalty      provided for in the SettlementAgreement. |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4. | Reporting |
|----|-----------|

|   | 4.1. | RMDX      shall report License Base Revenue in the Management      Discussion and Analysis section of its SEC 10-K and 10-Q filings as      follows: |
|--------|------|------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 4.2. | RMDX      will provide STOP with a quarterly report summarizing the royalty payments      for the current quarter and any adjustments to the rolling advance      required by section 5 of the Settlement  Agreement. |
|--------|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 4.3. | RMDX      will provide STOP with a separate and confidential report each quarter,      which will summarize and reconcile the revenues associated with sections      1, 2, and 3 above, including all individual billable unit days supporting      the revenues reported herein.  The report will be produced in a      format mutually acceptable to both parties.  The purpose of this      separate report will only be to allow STOP to confirm that RMDX has      calculated royalties consistent with the terms of the Settlement      Agreement. The content of this report is strictly confidential and shall      not be used or disclosed by STOP for any purpose other than to confirm      that RMDX has calculated royalties consistent with the provisions of the      Settlement Agreement. |
|--------|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| RMDX      Revenues for the YE/QE 00/00/00                               | RMDX      Revenues | Rolling      Advance Adjustment (if any) |
|-------------------------------------------------------------------------|--------------------|------------------------------------------|
| License      Base Revenues                                              | $A                 | $ +      / -                             |
| Revenues      from monitoring services not within License Base Revenues | $B                 | N/A                                      |
| Revenues      from case management and other related services           | $C                 | N/A                                      |
| TOTAL      ties to filings                                              | $A      + $B + $C  | $      +/-                               |

----

| SATELLITE      TRACKING OF PEOPLE, LLC (a/k/a STOP, LLC) and MICHELLE ENTERPRISES,      LLC, Plaintiff, v. PRO      TECH MONITORING, INC., OMNILINK SYSTEMS, INC., and SECUREALERT,      INC., Defendants. | )))))))))))))  |   CASE      NO. 2:08-CV-116 (CE)            JURY      TRIAL DEMANDED    |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

|   |                                |   |
|--------|-------------------------------------|--------|
|   | CHARLES      EVERINGHAM IV          |
|   | UNITED      STATES MAGISTRATE JUDGE |

----

----